Search Results
Aug 12, 2026, 08:33 ET Londian Wason, líder mundial en láminas de cobre, anuncia el precio de su oferta pública inicial ampliada
EBITDA ajustado alcanzó los 868,851 millones de RMB (unos 124,244 millones de dólares estadounidenses). En términos de I+D, al 31 de diciembre de 2025, la compañía contaba con un equipo de I+D dedicado de 428 profesionales, con 634 patentes registradas y 168 solicitudes de patente pendientes en China. También
More news about: LONDIAN WASON NEW ENERGY TECH INC.
Aug 12, 2026, 08:30 ET Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
generative chemistry platform, which integrates more than 40 carefully selected models and multiple supporting application modules. First, Insilico's R&D team uploaded the crystal structure of the target–small molecule complex to the platform to analyze key binding sites and interaction patterns in detail.
More news about: Insilico Medicine
Aug 12, 2026, 08:30 ET Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia
Visual Analogue Scale and the Sheehan Disability Scale The EQ Visual Analogue Scale (EQ-VAS) is the second component of the 5-level EQ 5D (EQ-5D-5L). The EQ-VAS is a visual scale ranging from 0 "the worst health you can imagine" to 100 "the best health you can imagine" that assesses a patient's
More news about: Neurocrine Biosciences, Inc.
Aug 12, 2026, 08:17 ET Ivonescimab Plus Chemotherapy Approved for First-Line Squamous NSCLC; HARMONi-6 Establishes New Gold Standard in Lung Cancer Treatment
best-in-class innovative biological medicines. Founded in 2012, Akeso has built a comprehensive R&D innovation ecosystem anchored by its proprietary Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform,
More news about: Akeso, Inc.
Aug 12, 2026, 08:12 ET TuMeke Launches Coaching Cues, Bringing Instant, AI-Powered Guidance Into Ergonomic Assessments
ergonomics, helping organizations identify and reduce workplace musculoskeletal injury risk. Its computer vision platform turns job video into automated 3D ergonomic assessments and actionable recommendations, with no wearables, sensors, or specialized equipment required. TuMeke enables safety and ergonomics
More news about: TuMeke, Inc.
Aug 12, 2026, 08:01 ET Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant Staphylococcus
More news about: Acurx Pharmaceuticals, Inc.
Aug 12, 2026, 07:30 ET Horizon Petroleum Provides an Operations Update for its Poland Operations and Confirms Wellbore Integrity at the Lachowice 7 well
Mcf/dthousand cubic feet per dayBoe/d
More news about: Horizon Petroleum Ltd.
Aug 12, 2026, 07:12 ET CGTN Español: Innovación en Shenzhen: conectando China con la región de Asia-Pacífico
antes no podían acceder fácilmente a la IA industrial se beneficien de ella. Esa es, sin duda, la tendencia de futuro", djio Shi Xiaoliang, director de I+D de Productos de SmartMore.Y en APEC China 2026, con la innovación entre las prioridades de la región, Shenzhen mostrará cómo su tecnología y su
More news about: CGTN Español
Aug 12, 2026, 07:09 ET Anamana Announces Season 2 of Breakout Hit 'The Playboy Got Knocked Up'
but with recurrent drift of the chosen global art direction. Both Xiaopi and Linnea juxtaposed the scenes that embodied their desired 2.5D look and feel against the 3D hyperrealistic scenes they ultimately compromised on to deliver the series on time for release.Still, the team praised Anamana Studio
More news about: Anamana
Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
on fair value of ZEC holdings and net loss; (c) the risk that the price of the Company's common stock may be highly correlated to the price of ZEC; (d) the risk that the Company will fail to realize the anticipated benefits of the ZEC digital asset treasury strategy or the investment in
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
on fair value of ZEC holdings and net loss; (c) the risk that the price of the Company's common stock may be highly correlated to the price of ZEC; (d) the risk that the Company will fail to realize the anticipated benefits of the ZEC digital asset treasury strategy or the investment in ZODL; (e) risks
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 07:00 ET Insurify Names Former KAYAK AI Leader Jake Bouvrie as Its First Chief AI Officer
firsthand. Jake combines deep machine learning research with operating experience across insurance, a global consumer marketplace, and enterprise R&D. He's the right leader to help us translate the opportunities of AI into measurable value.""Over the past two decades, AI has moved from research
More news about: INSURIFY, Inc.
Aug 12, 2026, 07:00 ET Defense Metals Invited by Natural Resources Canada to Submit a Full Project Proposal for its Wicheeda Processing Feasibility Program
Aug. 12, 2026 /PRNewswire/ -- Defense Metals Corp. ("Defense Metals" or the "Company"; (TSXV: DEFN) (OTCQB: DFMTF) (FSE:35D) announces that Natural Resources Canada ("NRCan") has invited the Company to submit a Full Project Proposal under its Critical Minerals Research,
More news about: Defense Metals Corp.
Aug 12, 2026, 06:55 ET Trimble Announces Second Quarter 2026 Results and Raises Full Year Guidance
Restructuring and other costs(D)2.5
More news about: Trimble
Aug 12, 2026, 06:51 ET 바레인, 오는 10월 개최되는 핀테크 포워드 2026 준비에 나서
multimedia:https://www.prnewswire.com/kr/news-releases/uBC14uB808uC778u002Cu002DuC624uB294u002Du0031u0030uC6D4u002DuAC1CuCD5CuB418uB294u002DuD540uD14CuD06Cu002DuD3ECuC6CCuB4DCu002Du0032u0030u0032-302849632.htmlSOURCE
More news about: Bahrain EDB
Aug 12, 2026, 06:50 ET Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
the same periods in 2025. Both periods reflect a $2.1 million grant receivable recorded under the new R&D law as a reduction of R&D expenses. The Company expects to continue to incur R&D expenses as the RELEASE study progresses and additional preclinical and clinical programs advance.Selling,
More news about: Protalix BioTherapeutics, Inc.
Aug 12, 2026, 06:50 ET 넥스티어의 하이마운트 다이렉트 드라이브 액추에이터, 소프트웨어 정의 차량을 위한 콕핏 설계 자유도 확보
multimedia:https://www.prnewswire.com/kr/news-releases/uB125uC2A4uD2F0uC5B4uC758u002DuD558uC774uB9C8uC6B4uD2B8u002DuB2E4uC774uB809uD2B8u002DuB4DCuB77CuC774uBE0Cu002DuC561uCD94uC5D0uC774uD130u002C-302849629.htmlSOURCE
More news about: Nexteer Automotive
Aug 12, 2026, 06:30 ET Bio-Techne Declares Dividend
provides high–quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer–focused brands: R&D Systems™, Bio–Techne Spatial™, and Bio–Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
provides high‑quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer‑focused brands: R&D Systems™, Bio‑Techne Spatial™, and Bio‑Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:06 ET CGTN Spanish: Innovation in Shenzhen: Connecting China with the Asia-Pacific Region
previously could not easily access industrial AI to benefit from it. This is undoubtedly the future trend," said Shi Xiaoliang, Director of Product R&D at SmartMore.At APEC China 2026, with innovation among the region's priorities, Shenzhen will demonstrate how its technology and industrial
More news about: CGTN Spanish
Aug 12, 2026, 06:00 ET Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
six months ended June 30, 2026, net loss was $8.3 million, compared to $3.6 million for the same period in 2025.Research and development (R&D) expenses were $2.8 million for the three months ended June 30, 2026, compared to $0.9 million for the same period in 2025. The increase was primarily
More news about: Eloxx Pharmaceuticals, Inc.
Aug 12, 2026, 05:59 ET Apotex Announces First Quarter 2027 Results
provisions of the Company's share-based compensation in connection with the IPO.R&D expenses were $39 million, up $1 million compared to prior year. R&D spend represented 5% of net sales compared to 3% in prior year. The higher research and development expenses as
More news about: Apotex Health Corp.
Aug 12, 2026, 05:45 ET Odine and OdineLabs File Two Patent Applications Focused on Enterprise AI Technologies
integration, and AI-powered product innovation, has filed two patent applications together with its subsidiary OdineLabs, further strengthening its R&D efforts in artificial intelligence and next-generation software technologies. The applications cover technologies designed to enable AI agents to understand
More news about: Odine
Aug 12, 2026, 05:30 ET Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
1-800-LillyRx.Lilly's lawsuits include:Eli Lilly & Co. v. Aesthetic Envy Cosmetic Centers LLC, d/b/a Aesthetic Envy (N.D. Cal.)Eli Lilly & Co. v. Astra LLC, d/b/a Astra Peptides (W.D. Tex.)Eli Lilly & Co. v. Legendary Peptides, LLC (E.D. Tex.)Eli
More news about: Eli Lilly and Company